Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1179

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 4
Chunk 1179
---
 $6.382 per share and are exercisable
upon issuance, or January 30, 2025, and expire twenty-four months from the date of issuance, or January 30, 2027. 

The January 2025 Offering closed on January 30,
2025, resulting in net proceeds to the Company of approximately $804,346, after deducting the placement agent fees and other offering
expenses paid by the Company.

F-36

February 2025 Offering

On February 5, 2025, the Company entered into
a securities purchase agreement with certain institutional investors pursuant to which the Company sold, in a registered direct offering
an aggregate of 300,700 shares of common stock at a purchase price of $3.575 per share (the “February 2025 Offering”). The
shares were offered pursuant to a “shelf” registration statement on Form S-3 (Registration No. 333-280796), which was declared
effective by the SEC on July 18, 2024, as supplemented by a prospectus supplement and accompanying base prospectus filed with the SEC
on February 6, 2025.

In a concurrent private placement, the Company
also issued to the investors unregistered warrants (the “February 2025 Warrants”) to purchase up to an aggregate of 300,700
shares of common stock at an exercise price of $2.95 per share. The February 2025 Warrants are exercisable upon issuance, or February
6, 2025, and expire twenty-four months from the date of issuance, or February 8, 2027.

As compensation for acting as the placement agent
for the February 2025 Offering, the Company paid H.C. Wainwright & Co., LLC a cash transaction fee equal to 7.5% of the aggregate
gross cash proceeds in the offering and a management fee equal to 1.0% of the aggregate gross cash proceeds in the offering. The Company
also issued to H.C. Wainwright & Co., LLC warrants (the “February 2025 Placement Agent Warrants”) to purchase up to 22,554
shares of common stock. The February 2025 Placement Agent Warrants have an exercise price equal to $4.469 per share and are exercisable
upon issuance, or February 6, 2025, and expire twenty-four months from the date of issuance, or February 8, 2027. 

The February